Notes
Slide Show
Outline
1
Managing Chronic Pain



  • Palliative Care Institute of
  • Southeast Louisiana


  • Hospice of St. Tammany
  • Covington, LA
2
Introduction
  • 50 million people suffer from chronic pain
  • Treatment with opioids is safe and effective
  • New understanding of CNS changes in chronic pain provides rationale for treatment
  • Relief from suffering is our goal


3
How to Manage Pain Effectively and Efficiently
  • Assessing Pain
  • Difference between Acute and Chronic
  • Treatment of Pain
  • Specific Opioids
  • Adjuvants for Pain
  • Side-effects
  • Importance of Teamwork
4
Assessing Pain
  • Detailed description of pain
  • What makes it better or worse
  • Effect on emotional, social status
  • Do a physical assessment
  • Review diagnostic and lab data
  • Reassess often to adjust treatment


5
Acute Pain
  • Pathway for acute pain perception is conventional
  • Duration is short
  • Endorphins and enkephalins are released by CNS to block pain perception
  • Opioids are effective for acute pain



6
Chronic Pain
  • Prolonged pain impulses cause “burn-out” of the AMPA receptors involved in pain transmission in the spinal cord
  • Endorphins become less effective
  • NMDA receptors, normally quiescient, are activated, causing changes in pain transmission and behavior
7
NMDA Effects in Chronic Pain
  • Windup
  • Neural remodeling
  • Activation of NK-1 receptors
  • Afferent becomes efferent
  • Neurogenic inflammation
8
Treating Pain with Opioids
  • Nociceptive(Somatic and Visceral) and Neuropathic Pain


  • WHO 3-step analgesic ladder
  •     Step 1: Mild analgesics: APAP, Propoxyphene, NSAIDS
  •     Step 2: Moderate analgesics: Codeine,  Hydrocodone/APAP, Oxycodone/APAP, Tramadol
  •      Step 3:  Strong Opioids





9
Prescribing Opioids for Chronic Pain- General Principles
  • Use WHO pain ladder to select analgesic
  • Around-the-clock, q. 3-4 hr.
  • Assess frequently, adjust dose
  • Add up total opioid taken q. 24hr.
  • Select long-acting opioid q. 12 hr.
  • Use short-acting opioid for breakthrough pain prn.
  • Use one short- and one long-acting
  • Reassess to titrate dose
10
Equianalgesic Doses if Morphine = 10 mg p.o.
  • Dilaudid(hydromorphone= 2mg
  • Oxycodone       = 5-10 mg
  • Hydrocodone    =15 mg
  • Codeine            =  60mg
  • Ultram(tramadol) =50 mg
  • Demerol(merperidine) =50 mg
  • Fentanyl(duragesic)=see slide 13
  • Levorphanol           = 1-2 mg
11
 
12
Step 3 Strong Opioids
  • Morphine
  • Oxycodone
  • Dilaudid (Hydromorphone)
  • Fentanyl
  • Methadone
  • Levorphanol
13
Morphine
  • Usual 1st. choice for moderate, severe pain. Begin low, 15mg q 3-4 hr. Titrate ,reassess often.
  • No ceiling
  • Resp. depression rare in chronic pain patients.
  • High doses: metabolites = nausea,dysphoria, muscle jerks
14
Dilaudid- hydromorphone
  • Beginning dose 2-4 mg q 3-4 hr. Very effective, similar to MS.
  •  Less nausea. No ceiling. Often used orally for breakthrough pain and i.v.
  •  No sustained-release form.
  •  2 mg = 10 mg MS
15
Oxycodone
  • Starting oral dose 5-10 mg q 3-4 hr. Very effective
  • Less nausea, less troublesome metabolites.Combined with ASA and APAP (Percocet,etc.), limits ceiling.
  • Expensive sustained-release form (Oxycontin), no ceiling. Watch for illegal diversion. Oxycontin 10,20,40,80mg.
  •  Liquid concentrate 20mg/ml useful buccally in the dying, as is MS(Roxanol).
16
Duragesic (Fentanyl)
  • Duragesic patch: use care in opioid- naïve patient-use 25 mcg/hr first, after pain controlled by short-acting opioid.
  •  To calculate dose, convert any and all opioids to their morphine-equivalent/24 hr first.
  • 12 hr delay in onset and offset due to skin reservoir absorption.
17
Duragesic (cont’d)
  • Fever increases absorption rate. Avoid skin with scant subcut. fat.


  • 25mcg patch= 50 mg MS /24 hrs
  • 50  ‘         ‘    = 100 mg     “
  • 75  “         “   = 150 mg     “
  • 100  “      “   =  200mg       “
  •        (approx.)
18
Methadone and Levorphanol
  • Under-used, not marketed


  • NMDA receptor-blocking activity makes these, especially methadone, the best choice for neuropathic and complex chronic pain
  • Levorphanol is 4-8x stronger than MS: longer ½ life (q 6 hrs)
19
Advantages of Methadone
  • Long duration of action
  • Short initial distribution half-life
  • No active metabolites
  • No ceiling dose
  • NMDA receptor-blocker action in spinal cord (important in neuropathic and chronic pain)
  • Cost: approx. $20-25/month( vs. $200-500/mo. for hydromorphone,sust.act. morphine,oxycodone,fentanyl patch.
20
Advantages (cont’d)
  •     Potency at least equal to morphine
  • Oral, rectal absorption excellent
  • Low incidence of side-effects
  • Less constipating
  • Lower incidence of tolerance
  • Available for iv infusion use
  • Most important,methadone is both a mu opioid agonist and an NMDA receptor antagonist as it relates to pain relief


21
Disadvantages
  • Stigma and association with substance-abuse
  • Accumulation due to long and variable elimination half-life in some persons
  • Said to be hard to convert to and from other opioids
  • Fear of regulators
  • Lack of education and experience
22
Cost Comparison of  Opioids ( 30 day supply)
  • Duragesic Patch 25mcg/hr   $ 140
  • Duragesic Patch 100 mcg/hr $ 430
  • Oxycontin 40 mg q 12 hr       $ 250
  • MS contin 60 mg q 12 hr       $ 210
  • Dilaudid 4 mg q 4 hr ATC      $ 118
  • Percocet 5 mg q 4 hr ATC     $ 210
  • Levorphanol 2 mg q 6 hr       $ 120
  • Methadone 10 mg q 8 hr       $   20
23
From the literature:
  • 108 outpatients with cancer pain on opioids
  • 103 successfully switched to methadone- oral q 8 hrs with significant reduction of pain


  • Bruera,E. et al, proceedings of the 9th World Congress on Pain,2000, p.957.
24
From the literature:
  • 52 prospective, consecutive patients with either uncontrolled cancer pain on opioids or intolerable side-effects switched to methadone.
  •  All had significant reduction of pain and significantly less nausea, vomiting, constipation, and drowsiness.
  •     Mercandante, S. et al, J. of Clinical Oncology. 2001; 19:2898-2904
25
Personal experience: Prescribing Methadone 2001-2003
  • Palliative Care Consults(total) 140:
  •    Methadone for Chronic pain: 88
  •       Excellent relief( pain reduced from 7-10 to 0-3) :   50
  •       Fair relief (pain reduced to 4-6):                           18
  •       No benefit or side-effects: 20
  •    ( Nausea 6, Sedation 12, Depression 2)
26
Adjuvants for Pain
  • For Neuropathic pain:
  •         Tricyclic antidepressants-desipramine, nortriptyline preferred
  •         Anticonvulsants- valproic acid, gabapentin preferred


  • For bone and soft-tissue pain:
  •         NSAIDs,corticosteroids,palliative radiation,biphosphonates


  •     For visceral pain: corticosteroids,H-2 blockers,metoclopropamide
27
Side-effects of Treatment
  • Opioid adverse effects: nausea,constipation,somnolence,  dysphoria, muscle jerks, itching,      respiratory depression
  • Neuropathic adjuvant side-effects: dizziness ,sleepiness, low BP, liver toxicity(uncommon)
  • NSAID side-effects: nausea, GI ulcer or bleeding, edema,decreased renal function



28
Importance of Teamwork
  • Complex chronic pain, especially if caused by life-threatening disease, is best treated by a team.
  • The diverse talents of physician, nurse, social worker, chaplain, working together offers comprehensive control of physical, emotional, and spiritual pain.
  • Palliative care is for ALL patients who are suffering.